BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28771681)

  • 41. Drug Receives New Indication for Juvenile Myelomonocytic Leukemia.
    Aschenbrenner DS
    Am J Nurs; 2022 Sep; 122(9):25. PubMed ID: 36005792
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A genome-wide search for epigenetically [corrected] regulated genes in zebra finch using MethylCap-seq and RNA-seq.
    Steyaert S; Diddens J; Galle J; De Meester E; De Keulenaer S; Bakker A; Sohnius-Wilhelmi N; Frankl-Vilches C; Van der Linden A; Van Criekinge W; Vanden Berghe W; De Meyer T
    Sci Rep; 2016 Feb; 6():20957. PubMed ID: 26864856
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Juvenile myelomonocytic leukemia.
    Satwani P; Kahn J; Dvorak CC
    Pediatr Clin North Am; 2015 Feb; 62(1):95-106. PubMed ID: 25435114
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phenotypic profiling of CD34
    Bugarin C; Antolini L; Buracchi C; Matarraz S; Coliva TA; Van der Velden VH; Szczepanski T; Da Costa ES; Van der Sluijs A; Novakova M; Mejstrikova E; Nierkens S; De Mello FV; Fernandez P; Aanei C; Sędek Ł; Strocchio L; Masetti R; Sainati L; Philippé J; Valsecchi MG; Locatelli F; Van Dongen JJM; Biondi A; Orfao A; Gaipa G
    Haematologica; 2024 Feb; 109(2):521-532. PubMed ID: 37534527
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Multiple granular cell tumours in a patient with Noonan's syndrome and juvenile myelomonocytic leukaemia].
    Castagna J; Clerc J; Dupond AS; Laresche C
    Ann Dermatol Venereol; 2017 Nov; 144(11):705-711. PubMed ID: 28728859
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Juvenile myelomonocytic leukaemia and Noonan syndrome.
    Strullu M; Caye A; Lachenaud J; Cassinat B; Gazal S; Fenneteau O; Pouvreau N; Pereira S; Baumann C; Contet A; Sirvent N; Méchinaud F; Guellec I; Adjaoud D; Paillard C; Alberti C; Zenker M; Chomienne C; Bertrand Y; Baruchel A; Verloes A; Cavé H
    J Med Genet; 2014 Oct; 51(10):689-97. PubMed ID: 25097206
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Blastic transformation of juvenile myelomonocytic leukemia caused by the copy number gain of oncogenic KRAS.
    Osumi T; Kato M; Ouchi-Uchiyama M; Tomizawa D; Kataoka K; Fujii Y; Seki M; Takita J; Ogawa S; Uchiyama T; Ohki K; Kiyokawa N
    Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28244637
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adults with germline CBL mutation complicated with juvenile myelomonocytic leukemia at infancy.
    Muraoka M; Okuma C; Kanamitsu K; Ishida H; Kanazawa Y; Washio K; Seki M; Kato M; Takita J; Sato Y; Ogawa S; Tsukahara H; Oda M; Shimada A
    J Hum Genet; 2016 Jun; 61(6):523-6. PubMed ID: 26911351
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia and juvenile myelomonocytic leukemia].
    Shao Q; Wang ZD; Zheng XL; Dong L; Han DM; Yan HM; Wang HX; Duan LN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1058-62. PubMed ID: 25130828
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PTEN deficiency is a common defect in juvenile myelomonocytic leukemia.
    Liu YL; Castleberry RP; Emanuel PD
    Leuk Res; 2009 May; 33(5):671-7. PubMed ID: 19010541
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical parameter-based prediction of DNA methylation classification generates a prediction model of prognosis in patients with juvenile myelomonocytic leukemia.
    Imaizumi T; Meyer J; Wakamatsu M; Kitazawa H; Murakami N; Okuno Y; Yoshida T; Sajiki D; Hama A; Kojima S; Takahashi Y; Loh M; Stieglitz E; Muramatsu H
    Sci Rep; 2022 Aug; 12(1):14753. PubMed ID: 36042365
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Persistence of both cords nine months post double cord blood transplantation for juvenile myelomonocytic leukaemia.
    Yadav SP; Dhingra N; Saxena R; Sachdeva A
    Hematol Oncol Stem Cell Ther; 2013 Jun; 6(2):79-80. PubMed ID: 23669498
    [No Abstract]   [Full Text] [Related]  

  • 53. Spectrum of molecular defects in juvenile myelomonocytic leukaemia includes ASXL1 mutations.
    Sugimoto Y; Muramatsu H; Makishima H; Prince C; Jankowska AM; Yoshida N; Xu Y; Nishio N; Hama A; Yagasaki H; Takahashi Y; Kato K; Manabe A; Kojima S; Maciejewski JP
    Br J Haematol; 2010 Jul; 150(1):83-7. PubMed ID: 20408841
    [TBL] [Abstract][Full Text] [Related]  

  • 54. RAS pathway mutations in juvenile myelomonocytic leukemia.
    Emanuel PD
    Acta Haematol; 2008; 119(4):207-11. PubMed ID: 18566538
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Global DNA methylation profiling reveals new insights into epigenetically deregulated protein coding and long noncoding RNAs in CLL.
    Subhash S; Andersson PO; Kosalai ST; Kanduri C; Kanduri M
    Clin Epigenetics; 2016; 8():106. PubMed ID: 27777635
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combining MeDIP-seq and MRE-seq to investigate genome-wide CpG methylation.
    Li D; Zhang B; Xing X; Wang T
    Methods; 2015 Jan; 72():29-40. PubMed ID: 25448294
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeted inhibition of genome-wide DNA methylation analysis in epigenetically modulated phenotypes in lung cancer.
    Dai SP; Xie C; Ding N; Zhang YJ; Han L; Han YW
    Med Oncol; 2015 Jun; 32(6):615. PubMed ID: 25926333
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA fingerprints in juvenile myelomonocytic leukemia (JMML) identified miR-150-5p as a tumor suppressor and potential target for treatment.
    Leoncini PP; Bertaina A; Papaioannou D; Flotho C; Masetti R; Bresolin S; Menna G; Santoro N; Zecca M; Basso G; Nigita G; Veneziano D; Pagotto S; D'Ovidio K; Rota R; Dorrance A; Croce CM; Niemeyer C; Locatelli F; Garzon R
    Oncotarget; 2016 Aug; 7(34):55395-55408. PubMed ID: 27447965
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Trissomy of chromosome 8 and juvenile myelomonocytic leukemia.
    Valera ET; Brassesco MS; Scrideli CA; Tone LG
    J Pediatr Hematol Oncol; 2012 May; 34(4):e170-1. PubMed ID: 22531497
    [No Abstract]   [Full Text] [Related]  

  • 60. Juvenile myelomonocytic leukemia presenting with features of neonatal hemophagocytic lymphohistiocytosis and cutaneous juvenile xanthogranulomata and successfully treated with allogeneic hemopoietic stem cell transplant.
    Arachchillage DR; Carr TF; Kerr B; Hawkins K; Kelsey A; Judge M; Wynn RF
    J Pediatr Hematol Oncol; 2010 Mar; 32(2):152-5. PubMed ID: 20168243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.